Quick Answer
Xenon Pharmaceuticals Inc. reported Total Revenue of $311.0 thousand for the year ending 2017.
- Xenon Pharmaceuticals Inc. showed an increase of +0.0% in Total Revenue from 2017 to 2017.
- This data is from Xenon Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2019.
- XBRL data for this metric is available from 2012 to 2017 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $5.39 million | Q2 2013: $5.60 million | Q3 2013: $10.79 million | Q4 2013: $5.58 million | Q1 2014: $5.00 million | Q2 2014: $5.30 million | Q3 2014: $13.19 million | Q4 2014: $4.88 million | Q1 2015: $4.01 million | Q2 2015: $4.05 million | Q3 2015: $4.29 million | Q4 2015: $3.23 million | Q1 2016: $601.0 thousand | Q2 2016: $413.0 thousand | Q3 2016: $413.0 thousand | Q4 2016: $376.0 thousand | Q1 2017: $16.0 thousand | Q2 2017: $15.0 thousand | Q3 2017: $264.0 thousand | Q3 2017: $264.0 thousand | Q4 2017: $16.0 thousand.
- Over the full 7 years of available data (2012 to 2017), Xenon Pharmaceuticals Inc.'s Total Revenue has declined by 97.8%.
- Historical annual values: Fiscal year 2017: $311.0 thousand | Fiscal year 2017: $311.0 thousand | Fiscal year 2016: $1.80 million | Fiscal year 2015: $15.58 million | Fiscal year 2014: $28.37 million | Fiscal year 2013: $27.36 million | Fiscal year 2012: $14.31 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: